Hypertension after kidney transplantation

American Journal of Kidney Diseases

Volumn 43, Issue 6, 2004, Pages 1071-1081

  Kasiske, Bertram L ^a   Anjum, Shakeel ^b   Shah, Rajiv ^b   Skogen, Jeffrey ^b   Kandaswamy, Chitra ^b   Danielson, Barbara ^b   O'Shaughnessy, Eileen A ^b   Dahl, David C ^b   Silkensen, John R ^b   Sahadevan, Meena ^b   Snyder, Jon J ^b  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Acute rejection; Allograft failure; Blood pressure (BP)

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN A; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIABETES MELLITUS; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

EID: 2542464211     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.03.013     Document Type: Article

References (25)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:605-612, 2000
2. Cosio FG, Pelletier RP, Pesavento TE, et al: Elevated blood pressure predicts the risk of acute rejection in renal allograft recipients. Kidney Int 59:1158-1164, 2001
3. Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J: Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation. Transplantation 75:1989-1995, 2003
4. Anjum S, Andany MA, McClean JC, Danielson B, Kasiske BL: Defining the risk of elective cyclosporine withdrawal in stable kidney transplant recipients. Am J Transplant 2:179-185, 2002
5. Kasiske BL, Johnson HJ, Goerdt PJ, et al: A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients. Am J Kidney Dis 30:639-645, 1997
6. Chobanian AV, Bakris GL, Black HR, et al: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289:2560-2572, 2003
7. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
8. Cosio FG, Dillon JJ, Falkenhain ME, et al: Racial differences in renal allograft survival: The role of systemic hypertension. Kidney Int 47:1136-1141, 1995
9. Opelz G, Wujciak T, Ritz E, for the Collaborative Transplant Study: Association of chronic kidney graft failure with recipient blood pressure. Kidney Int 53:217-222, 1998
10. Kasiske BL: Possible causes and consequences of hypertension in stable renal transplant patients. Transplantation 44:639-643, 1987
11. Curtis JJ, Lucas BA, Kotchen TA, Luke RG: Surgical therapy for persistent hypertension after renal transplantation. Transplantation 31:125-128, 1981
12. Fricke L, Doehn C, Steinhoff J, Sack K, Jocham D, Fornara P: Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy? Transplantation 65:1182-1187, 1998
13. van der Woude FJ, van Son WJ, Tegzess AM, et al: Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis. Nephron 39:184-188, 1985
14. Ahmad T, Coulthard MG, Eastham EJ: Reversible renal failure due to the use of captopril in a renal allograft recipient treated with cyclosporin. Nephrol Dial Transplant 4:311-312, 1989
15. Garcia TM, da Costa JA, Costa RS, Ferraz AS: Acute tubular necrosis in kidney transplant patients treated with enalapril. Ren Fail 16:419-423, 1994
16. Williams ME, Shaffer D: ACE inhibitor-induced transplant acute renal failure due to donor fibromuscular dysplasia. Nephrol Dial Transplant 14:760-764, 1999
17. US Renal Data System: USRDS 2003 Annual Data Report. The National Institutes of Health, National Institute of Diabetes and Digestive Kidney Diseases, Bethesda, MD, 2003
18. Curtis JJ: Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 2:S243-S245, 1992 (suppl 12)
19. Sorof JM, Sullivan EK, Tejani A, Portman RJ: Antihypertensive medication and renal allograft failure: A North American Pediatric Renal Transplant Cooperative Study report. J Am Soc Nephrol 10:1324-1330, 1999
20. Mange KC, Cizman B, Joffe M, Feldman HI: Arterial hypertension and renal allograft survival. JAMA 283:633-638, 2000
21. Mange KC, Feldman HI, Joffe MM, Fa K, Bloom RD: Blood pressure and the survival of renal allografts from living donors. J Am Soc Nephrol 15:187-193, 2004
22. Mitsnefes MM, Khoury PR, McEnery PT: Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 143:98-103, 2003
23. Rigatto C, Foley RN, Kent GM, Guttmann R, Parfrey PS: Long-term changes in left ventricular hypertrophy after renal transplantation. Transplantation 70:570-575, 2000
24. Fernández-Fresnedo G, Escallada R, Rodrigo E, et al: Pulse pressure is an independent risk factor of cardiovascular disease in renal transplant patients. Transplant Proc 35:1730-1731, 2003
25. Sarnak MJ, Levey AS, Schoolwerth AC, et al: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42:1050-1065, 2003